Abstract:Electroencephalographic (EEG) signals have long been applied in the field of affective brain-computer interfaces (aBCIs). Cross-subject EEG-based emotion recognition has demonstrated significant potential in practical applications due to its suitability across diverse people. However, most studies on cross-subject EEG-based emotion recognition neglect the presence of inter-individual variability and negative transfer phenomena during model training. To address this issue, a cross-subject EEG-based emotion recognition through source selection with adversarial strategy is introduced in this paper. The proposed method comprises two modules: the source selection network (SS) and the adversarial strategies network (AS). The SS uses domain labels to reverse-engineer the training process of domain adaptation. Its key idea is to disrupt class separability and magnify inter-domain differences, thereby raising the classification difficulty and forcing the model to learn domain-invariant yet emotion-relevant representations. The AS gets the source domain selection results and the pretrained domain discriminators from SS. The pretrained domain discriminators compute a novel loss aimed at enhancing the performance of domain classification during adversarial training, ensuring the balance of adversarial strategies. This paper provides theoretical insights into the proposed method and achieves outstanding performance on two EEG-based emotion datasets, SEED and SEED-IV. The code can be found at https://github.com/liuyici/SSAS.
Abstract:The Coronavirus disease 2019 (COVID-19) was first identified in Wuhan, China, in early December 2019 and now becoming a pandemic. When COVID-19 patients undergo radiography examination, radiologists can observe the present of radiographic abnormalities from their chest X-ray (CXR) images. In this study, a deep convolutional neural network (CNN) model was proposed to aid radiologists in diagnosing COVID-19 patients. First, this work conducted a comparative study on the performance of modified VGG-16, ResNet-50 and DenseNet-121 to classify CXR images into normal, COVID-19 and viral pneumonia. Then, the impact of image augmentation on the classification results was evaluated. The publicly available COVID-19 Radiography Database was used throughout this study. After comparison, ResNet-50 achieved the highest accuracy with 95.88%. Next, after training ResNet-50 with rotation, translation, horizontal flip, intensity shift and zoom augmented dataset, the accuracy dropped to 80.95%. Furthermore, an ablation study on the effect of image augmentation on the classification results found that the combinations of rotation and intensity shift augmentation methods obtained an accuracy higher than baseline, which is 96.14%. Finally, ResNet-50 with rotation and intensity shift augmentations performed the best and was proposed as the final classification model in this work. These findings demonstrated that the proposed classification model can provide a promising result for COVID-19 diagnosis.
Abstract:Automatic segmentation of kidney and kidney tumour in Computed Tomography (CT) images is essential, as it uses less time as compared to the current gold standard of manual segmentation. However, many hospitals are still reliant on manual study and segmentation of CT images by medical practitioners because of its higher accuracy. Thus, this study focuses on the development of an approach for automatic kidney and kidney tumour segmentation in contrast-enhanced CT images. A method based on Convolutional Neural Network (CNN) was proposed, where a 3D U-Net segmentation model was developed and trained to delineate the kidney and kidney tumour from CT scans. Each CT image was pre-processed before inputting to the CNN, and the effect of down-sampled and patch-wise input images on the model performance was analysed. The proposed method was evaluated on the publicly available 2021 Kidney and Kidney Tumour Segmentation Challenge (KiTS21) dataset. The method with the best performing model recorded an average training Dice score of 0.6129, with the kidney and kidney tumour Dice scores of 0.7923 and 0.4344, respectively. For testing, the model obtained a kidney Dice score of 0.8034, and a kidney tumour Dice score of 0.4713, with an average Dice score of 0.6374.